Quest Diagnostics Incorporated updated earnings guidance for the full year of 2024. For the year, the company expects net revenues to be between $9.40 billion to $9.48 billion, Net revenues increase to be between 1.6% to 2.5%, Reported diluted EPS to be between $7.57 to $7.82 compared to the previous guidance of net revenues to be between $9.35 billion to $9.45 billion, Net revenues increase to be between 1.1% to 2.1%, Reported diluted EPS to be between $7.69 to $7.99.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
138.4 USD | +0.19% | +0.76% | +0.39% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.39% | 15.38B | |
+20.68% | 85.55B | |
-29.31% | 70.07B | |
+9.23% | 29.06B | |
-8.63% | 17.51B | |
+2.14% | 17.39B | |
+6.47% | 13.4B | |
+68.09% | 12.87B | |
+6.43% | 12.77B | |
+68.23% | 12.42B |
- Stock Market
- Equities
- DGX Stock
- News Quest Diagnostics Incorporated
- Quest Diagnostics Incorporated Updates Earnings Guidance for the Full Year of 2024